BioMarin Pharmaceutical Inc.
Commercial rare-disease biotech focused on genetically defined conditions, with late-stage skeletal and enzyme-replacement programs.
Rare genetic & skeletal disease · Biologics, peptides, small molecules & oligonucleotides · Commercial + Phase 3